Introducing iron isomaltoside 1000 (Monofer®)—development rationale and clinical experience

Patients with chronic kidney disease (CKD) often suffer from iron deficiency anaemia necessitating treatment with intravenous (IV) iron. Several studies demonstrate that oral iron is insufficient in these patients and that IV supplementation is a more effective treatment. Until now, use of available...

Descripción completa

Detalles Bibliográficos
Autor principal: Kalra, Philip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Supplement Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813791/
https://www.ncbi.nlm.nih.gov/pubmed/27045417
http://dx.doi.org/10.1093/ndtplus/sfr042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813791/
https://www.ncbi.nlm.nih.gov/pubmed/27045417
http://dx.doi.org/10.1093/ndtplus/sfr042

Ejemplares similares